arrow
S

Simon A. Smith

AstraZeneca
H指数:30
被引数:3,074

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Phase Ib/II study of ceralasertib, a selective inhibitor of ATR, in patients with relapsed or refractory MDS and CMML

Ib/II期研究:ceralasertib(一种ATR选择性抑制剂)在复发或难治性MDS和CMML患者中的研究

2026-07-020
OA
Tumor control and immune activation through palliative irradiation and ATR inhibition, PATRIOT Part C: a phase Ib trial

通过姑息性放疗和ATR抑制实现肿瘤控制和免疫激活,PATRIOT Part C:一项 Ib 期临床试验

2025-08-010
OAAI
Sculpting the tumour microenvironment by combining radiotherapy and ATR inhibition for curative-intent adjuvant immunotherapy
2024-08-130
OAAI
Durable responses to ATR inhibition with ceralasertib in tumors with genomic defects and high inflammation
2024-01-168
OAAI
Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor- Resistant Homologous Recombination-Deficient Ovarian Cancer
2023-04-2520
OA
Development of AZD2811, an aurora kinase B inhibitor, incorporated into an Accurin™ nanoparticle for use in haematological and solid cancers
2017-07-010
PRE
AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studies
2015-04-3048
PREAI